Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
2,845 total articles
Credo Technology (CRDO) just reported a blowout revenue quarter and ultra-high gross margins, yet the stock has pulled back into technical support and below its moving averages. I was bearish earlier; new data and product ramps force a rethink. This is a trade idea: aggressive long entry at current levels with a medium-to-high risk posture and a lo…
Telephone and Data Systems (TDS) is a post-sale telecom with a cleaner balance sheet, significant free cash flow and an under-appreciated valuation. We outline a long trade with precise entry, stop and target, driven by balance-sheet optionality and a plausible re-rating as management redeploys capital into fiber and tower leasing.
Bridgestone (BRDCY) has been hit by a risk-off move tied to recent geopolitical escalation that pushed cyclicals lower. Fundamentals remain intact: market cap ~$27.5B, P/E ~12.8, P/B ~1.15, dividend yield ~1.67% and active asset divestitures that should free cash. Technicals show oversold conditions (RSI ~31.6) and elevated short activity—condition…
Coca-Cola's brand moat and healthy cash generation make it an attractive defensive swing trade after a modest pullback; recent market flows that prize dividend resilience amplify the case, but high valuation, leverage and mixed technicals warrant a tight plan.
Xunlei (XNET) trades like a small-cap technology value stock despite recent strong headline earnings driven by investee gains. At roughly $394.7M market cap and a $6.28 share price, the risk/reward looks attractive for a mid-term swing trade if you size carefully and respect the stock's volatility.
AtaiBeckley (ATAI) is a clinical-stage psychedelics-focused biotech with Phase 3 momentum for BPL-003 (mebufotenin nasal spray) in treatment-resistant depression. With Phase 2a/2b data showing rapid, durable responses, FDA alignment, a planned Phase 3 start in Q2 2026, and $220.7M in runway into early 2029, I see an asymmetric risk/reward for a lon…
Kinross Gold (KGC) is trading below its short- and medium-term moving averages after a pullback, yet still commands a $34.7B market cap and reported record free cash flow in 2025. With a newly raised dividend and operational optionality across multiple jurisdictions, this is a tactical long trade: enter $29.00, stop $25.00, target $36.00 over a lon…
Carlisle (CSL) is a mature, cash-generative building-products play trading below its 50-day and 20-day averages after recent weakness. Strong free cash flow ($970.6M), a hefty ROE (41%), and an attractive EV/EBITDA (13.0) support a mid-term long. This trade idea proposes entry at $340.00, a stop at $312.00, and a target of $400.00 over a mid-term h…
Trip.com (TCOM) trades at a roughly $35.9B market cap with a P/E of 8.34 and PB of 1.52. The stock has been hit by a Chinese antitrust probe and related lawsuits, but core travel demand remains intact and technicals show the name near cyclical lows. This trade idea lays out an entry, stop and target for a long position with a 180-trading-day horizo…
Rocket Lab just moved from growth-only narrative to a vertically integrated space systems and defense play after a strategic acquisition and steady launch execution. Fundamentals and backlog support upside, but valuation is rich. This is a tactical mid-term long: entry $70.45, stop $60.00, target $95.00, horizon 45 trading days.
SM Energy (SM) looks cheap on several measures after combining with Civitas Resources. The company now has scale in the Permian, an explicit plan to prioritize free cash flow, a raised dividend and targeted asset sales. With EV/EBITDA near 4.3 and free cash flow of roughly $539M, SM is a value play with a clear catalyst set. Here's a practical trad…
MPLX offers a durable income floor (annualized distribution $4.31, yield ~7.1%) underpinned by stable, fee-based midstream cash flows and visible growth projects. Valuation is reasonable (market cap ~$58.3B, P/E ~11.9, EV/EBITDA ~14.1) and the balance sheet supports modest distribution growth. Trade plan: enter $57.50, stop $54.00, target $64.00 on…
FinVolution is trading on single-digit multiples, returning cash via a material buyback and dividend program that equals roughly 12% of market cap. Combine that with improving technicals and elevated short interest and you have an asymmetric, actionable long set-up for the next 45 trading days. Trade plan, triggers and clear stop laid out below.
Freeport-McMoRan (FCX) looks positioned for a sustained earnings run driven by stronger copper prices, production growth from Indonesia and healthy cash generation. With a market cap near $79.7B and EV/EBITDA around 9.7x, the stock still offers asymmetry for patient, risk-aware buyers. I’m upgrading to Buy and laying out a clear entry, stop and tar…
Herc Holdings (HRI) has sold off hard from its 52-week high after a deal-driven rerating and short-term technical weakness. The stock trades at an attractive EV/EBITDA of 6.6x and yields ~2.5%, and the H&E acquisition should lift scale and create $300M of synergies. The balance sheet and near-term free cash flow remain the main risks. We keep a Buy…
Escalating Shahed-style swarm drone attacks and rising geopolitical risk are triggering urgent procurement cycles for integrated missile and air-defense systems. Lockheed Martin sits squarely in the sweet spot with its Missiles and Fire Control lineup, backlog strength and cash generation. This trade idea lays out an actionable long with entry at $…
Nano Labs (NA) is a sub-$100M market-cap fabless semiconductor company focused on high-throughput and vision computing chips. The shares trade at roughly $3.04 with a market cap of ~$71.5M, a price-to-book under 1.0, and materially depressed revenue after a strategic pivot into crypto reserves. Between a cheap balance relative to book, insider buyi…
Clover Health is a physician-enablement and Medicare Advantage operator whose platform-driven approach and exposure to a fast-growing healthcare AI/insurtech market appear underappreciated by the market. At roughly $1.0B market capitalization and an EV/sales around 0.55, the stock looks mispriced relative to optionality from improved risk adjustmen…
Willis Towers Watson (WTW) is trading off recent AI disruption fears and technical weakness, but the company’s stable cash flow, reasonable valuation (PE ~17), recent strategic deals and a growing digital offering create an asymmetric risk/reward for a swing trade. Enter at $287.00, target $330.00, stop $273.00 for a mid-term trade (~45 trading day…
Quantum Computing Inc. reported a clear Q4 inflection: Q4 revenues of $198,000 (up 219% YoY), a sharply reduced net loss of $1.6M, and a $750M private placement that leaves the company with sizable cash to execute. The market cap of roughly $1.6B already prices in a lot of future upside, but the balance sheet, recent acquisition, and signs of comme…
DigitalOcean (DOCN) offers a differentiated, profitable exposure to AI application infrastructure focused on developers and SMBs. With $242M in recent quarterly revenue, a $970M ARR run-rate, 150% AI ARR growth, and growing enterprise customers, the stock can re-rate as the market recognizes sustainable AI demand. We lay out a long trade with entry…
Carlyle (CG) is a global investment manager with a strong fee and performance-income profile. At a market cap of ~$17.24B and trailing free cash flow of $1.48B, the stock offers an attractive FCF yield (~8.6%) and a 2.9% dividend yield. With manageable leverage (debt/equity ~0.52) and recent deal-related news that could unlock fees and realizations…
British American Tobacco (BTI) combines predictable cash flow, a 5.3% yield, and a modest 12.6x P/E multiple. For investors seeking defensive income and upside from re-rating and alternative-nicotine progress, a long trade at $58.11 with a $72 target and $52 stop balances yield capture and downside protection.
BTI trades at roughly 13x earnings today, delivers a 5.1% yield, and sits in the defensive consumer pocket that tends to hold up in downturns. This trade idea lays out an entry at $58.18, a stop at $53.00, and a target at $66.00 over a 180-trading-day horizon, with catalysts and risks that justify a patient, income-oriented long.
Energy Transfer (ET) offers a 7%+ distribution yield supported by rising distributable cash flow, a backlog of projects tied to export and data-center demand, and reasonable valuation metrics (P/E ~15.5, EV/EBITDA 8.8). This trade idea targets income with capital upside, sized for investors willing to tolerate midstream leverage and cyclical commod…
